Zepp Health Corp ADR Dossier - Source-backed chat

Zepp Health Corp ADR

ZEPPNYSE

SectorInformation Technology

IndustryTechnology Hardware, Storage & Peripherals

Beta (adjusted)1.60

Intrinsic Value $4.30median of 2 methodsbased on filings through 31 Dec 2025

Market Price $4.02Price as of 30 Sep 2026

Near fair valueIntrinsic value is 7% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $59M

Enterprise Value $61.4M

Shares Outstanding 14.7M diluted

Next Earnings Date4 Nov 2026

Last ex-dividend25 Mar 2022

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Zepp Health Corp (ZEPP) is undergoing a strategic transition from a low-margin hardware manufacturer to a premium, AI-driven hybrid training platform. The company has demonstrated robust top-line momentum, with Q1 2026 revenue growing 33.8% YoY to $51.5 million, driven by successful premium product launches (Amazfit Active Max, Active 3 Premium, T-Rex Ultra 2) and an expanded global partnership with HYROX. However, persistent unprofitability (adjusted net loss of $17.9 million in Q1 2026), rising operating expenses, and gross margins that remain significantly below pure-play peers like Garmin limit near-term upside. While the valuation is highly depressed relative to sales, a 'Hold' rating is recommended until the company demonstrates a clear, sustainable path to GAAP profitability and positive cash flow.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$53.01

Mean target$53.01

High · most bullish analyst$53.01

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$1.5020%

The bear case assumes that intense competition from dominant players (Apple, Garmin, Samsung) and rising memory component costs severely compress gross margins back to the mid-30s. High marketing and R&D expenses required to support new launches continue to drain cash, forcing the company to seek dilutive financing or toxic debt. Revenue growth decelerates to single digits as consumer discretionary spending weakens, causing the stock to test new lows.

Base CaseCentral scenario

$5.0050%

In the base case, Zepp continues to grow its Amazfit brand revenue at a moderate double-digit pace (15-20% annually) while gradually narrowing its operating losses. Gross margins hover in the high-30% range, occasionally touching 40% depending on product mix and component cost headwinds. The company remains in a net loss position for the majority of 2026 but maintains a stable cash cushion above $90 million, keeping the stock range-bound as the market waits for definitive proof of structural breakeven.

Bull CaseUpside scenario

$10.0030%

The bull case is centered on the successful monetization of the exclusive 3-year global HYROX partnership. If Amazfit becomes the default wearable across the HYROX365 ecosystem (spanning over 14,000 affiliated gyms, coaches, and 550,000+ athletes), it could drive a massive high-margin software/subscription and premium hardware replacement cycle. Combined with operating leverage from cost-cutting, this could push Zepp into sustained profitability by late 2026 or early 2027, triggering a significant valuation re-rating toward peer multiples.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong top-line growth with Q1 2026 revenue up 33.8% YoY, showing resilient demand for the Amazfit product lines.
Strategic expansion of the high-profile, exclusive 3-year global HYROX partnership, providing direct access to a highly engaged fitness community.
Substantial cash position of $103.2 million as of March 31, 2026, providing a buffer to fund the ongoing business turnaround.
Extremely low valuation multiples relative to historical sales volume, trading at a deep discount to peers like Garmin.

Key Investment Risks

Persistent unprofitability, with a GAAP net loss of $19.6 million and adjusted net loss of $17.9 million in Q1 2026.
Gross margins (37.7% in Q1 2026) remain structurally lower than premium competitors like Garmin, limiting overall scalability.
Rising operating expenses and foreign exchange headwinds ($1.8 million impact in Q1 2026) pressure the cost structure.
High competition in the smart wearables market from well-capitalized tech giants (Apple, Samsung, Google/Fitbit).

Thesis Invalidation Triggers

Quarterly gross margin dropping below 34% for two consecutive quarters.
Total cash and restricted cash falling below $75 million without a clear reduction in operating cash burn.
Deceleration of year-over-year revenue growth to under 10% in upcoming quarters.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.